Systems and methods for analyzing antibody co-formulations

A bead-based system with donor and acceptor beads and chemiluminescent dyes addresses the challenges of quantifying co-formulated biological molecules, offering precise detection and scalable analysis for multiple antigen-binding proteins.

JP2026505757APending Publication Date: 2026-02-18AMGEN INC
0 Cites 0 Cited by

Patent Information

Application Number
JP2025543245
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-01-30
Filing Date
2024-01-29
Publication Date
2026-02-18

AI Technical Summary

Technical Problem

There is a need for accurate systems and methods to determine the concentration of co-formulated biological molecules in pharmaceutical preparations, addressing analytical challenges, manufacturing issues, and stability concerns such as protein-protein interactions and protein aggregation in combination biologics.

Method used

A bead-based system using donor and acceptor beads with specific binding pairs and chemiluminescent dyes to detect and quantify multiple antigen-binding proteins, employing a homogeneous multiplex assay that generates amplified chemiluminescent signals upon photoexcitation.

Benefits of technology

Enables precise detection and quantification of multiple antigen-binding proteins in a single sample without washing, overcoming challenges of protein-protein interactions and aggregation, and providing scalable and adaptable analysis for various co-formulations.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The present disclosure provides a system and method for detecting and quantifying two or more different antigen-binding proteins in a sample, which includes donor beads, acceptor beads, and conjugated proteins that can be incubated with the sample and the antigen-binding proteins quantified by a proximity-based homogeneous assay.
Need to check novelty before this filing date? Find Prior Art